RxDoctor Payments Data

Andrew McKeon, MD

Neurology · Rochester, MNNPI 1558480087

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,700 of the $8,700 with a category attached, or 100.0%. 3 manufacturers reported payments, led by Genentech, Inc. at 45.4% of the total.

$8,700in general payments, 2019–2025

Across 6 payments — averaging $1450.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$4K
  • Janssen Research & Development, LLC$3K
  • F. Hoffmann-la Roche AG$2K
$174,063in research payments, 2019–2025

Across 14 payments — averaging $12,433 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$174K

What the payments were for

  • Consulting fees$8,700100%

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,700 in reported general payments places this provider in the 85th percentile of 434 neurology providers in Minnesota.

See all neurology providers in Minnesota

Medicare billing

Part B allowed, 2024
$25,697
Medicare patients
101
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FirdapseAmifampridine Phosphate16$752,043
Mycophenolate Mofetil24$3,289
Carbidopa-LevodopaCarbidopa/Levodopa36$878
Levetiracetam13$684
Pyridostigmine Bromide16$672
Gabapentin27$496
Diazepam21$363
Nortriptyline Hcl13$255
Donepezil Hcl19$252
Divalproex Sodium17$217
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim23$206
Baclofen14$118
Prednisone14$117
Tramadol Hcl19$100
Clonazepam15$51

Paid to pharmacies, not to this prescriber.

Other neurology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →